Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29308357 | 0.83 | LMNA (0.33) | LMNAMAPT | |
| SCHEMBL18854930 | 0.79 | LMNA (0.32) | LMNAMAPT | |
| SCHEMBL19981440 | 0.78 | DDR1 (0.32) | MAPT | |
| SCHEMBL29455621 | 0.77 | PDE2A (0.39) | LMNAMAPT | |
| SCHEMBL19981447 | 0.77 | PDE2A (0.39) | LMNAMAPT | |
| SCHEMBL21020024 | 0.75 | DDR1 (0.33) | LMNA | |
| SCHEMBL18866373 | 0.75 | POLB (0.40) | LMNA | |
| SCHEMBL17383211 | 0.74 | DDR1 (0.40) | — | |
| SCHEMBL18854929 | 0.73 | BRD4 (0.30) | — | |
| SCHEMBL25847648 | 0.72 | KDM4E (0.33) | MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12037326-B2 | Diaryl-azole compound and formulation for controlling harmful organism | NIPPON SODA CO., LTD. (JP) | 2024-07-16 | — | — | US | disclosed |
| US-12037326-B2 | Diaryl-azole compound and formulation for controlling harmful organism | NIPPON SODA CO., LTD. (JP) | 2024-07-16 | — | — | US | disclosed |
| US-12037326-B2 | Diaryl-azole compound and formulation for controlling harmful organism | NIPPON SODA CO., LTD. (JP) | 2024-07-16 | — | — | US | disclosed |
| CN-109689630-B | Diaryl azole compound and pest control agent | 日本曹达株式会社 | 2022-06-03 | — | — | CN | disclosed |
| EP-3514146-B1 | DIARYL- AZOLE COMPOUND AND FORMULATION FOR CONTROLLING HARMFUL ORGANISM | NIPPON SODA CO (JP) | 2022-03-16 | — | — | EP | disclosed |
| US-20220033384-A1 | DIARYL-AZOLE COMPOUND AND FORMULATION FOR CONTROLLING HARMFUL ORGANISM | NIPPON SODA CO., LTD. (JP) | 2022-02-03 | — | — | US | disclosed |
| US-11180485-B2 | Diaryl-azole compound and formulation for controlling harmful organism | NIPPON SODA CO., LTD. (JP) | 2021-11-23 | — | — | US | disclosed |
| EP-3514146-A1 | DIARYL AZOLE COMPOUND AND PESTICIDE | Nippon Soda Co., Ltd. (JP) | 2019-07-24 | — | — | EP | disclosed |
| EP-3514146-A1 | DIARYL AZOLE COMPOUND AND PESTICIDE | Nippon Soda Co., Ltd. (JP) | 2019-07-24 | — | — | EP | disclosed |
| US-20190185459-A1 | DIARYL-AZOLE COMPOUND AND FORMULATION FOR CONTROLLING HARMFUL ORGANISM | NIPPON SODA CO., LTD. (JP) | 2019-06-20 | — | — | US | disclosed |
| CN-109689630-A | Diaryl azole compound and pest control agent | 日本曹达株式会社 | 2019-04-26 | — | — | CN | disclosed |
| WO-2018052035-A1 | DIARYL AZOLE COMPOUND AND PESTICIDE | 日本曹達株式会社 | 2018-03-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220033384-A1 | DIARYL-AZOLE COMPOUND AND FORMULATION FOR CONTROLLING HARMFUL ORGANISM | CRY1, CRKL, CDC5L | LMNA 3711/4885MAPT 3768/4885 |
| US-20190185459-A1 | DIARYL-AZOLE COMPOUND AND FORMULATION FOR CONTROLLING HARMFUL ORGANISM | CRY1, CRKL, CDC5L | LMNA 3711/4885MAPT 3768/4885 |
| US-12037326-B2 | Diaryl-azole compound and formulation for controlling harmful organism | CRY1, CRKL, CDC5L | LMNA 3711/4885MAPT 3768/4885 |
| US-11180485-B2 | Diaryl-azole compound and formulation for controlling harmful organism | CRY1, CRKL, CDC5L | LMNA 3711/4885MAPT 3768/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.